TULVEGIO RIVOCERANIB

Elevar Therapeutics, Inc.

Application Filed: 2019-09-17
Trademark Application Details
Trademark Logo TULVEGIO RIVOCERANIB

The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".

Mark For: TULVEGIO RIVOCERANIB™ trademark registration is intended to cover the category of pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer. [all]

>Color is not claimed as a feature of the mark. The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".

Status

2024-04-11 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88620374
Mark Literal ElementsTULVEGIO RIVOCERANIB
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK. SERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2023-08-21
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameGrant R. Clayton
Attorney Docket NumberT13458
Law Office AssignedM80
Employee NameGARDNER, DAWNA BERYL

Timeline

2019-09-17Application Filed
2019-11-16Location: LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
2019-11-16Status: Live/Pending
2019-11-16Transaction Date
2021-06-22Published
2023-08-21Location: INTENT TO USE SECTION
2024-02-13Status: A fifth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Elevar Therapeutics, Inc.
Address2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UTAH UNITED STATES 84121
Legal Entity TypeCorporation
Legal Entity StateUTAH
Party: LSK BioPartners, Inc.
Address2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UTAH UNITED STATES 84121
Legal Entity TypeCorporation
Legal Entity StateUTAH

*multiple parties listed, check assignment documents for ownership information

Design Search Codes

02.11.14Finger pointing (gesture); Fingers walking (gesture); Gestures (OK, thumbs up, thumbs down, fingers walking, handshake, finger pointing); Hands and fingers forming the following: handshake, finger pointing, fingers walking, OK sign, and thumbs up or thumbs down; Handshake (gesture); OK gesture; Thumbs up or thumbs down (gesture)
021107Arms; Fingers; Hands; Human hands, fingers, arms
021114Finger pointing (gesture); Fingers walking (gesture); Gestures (OK, thumbs up, thumbs down, fingers walking, handshake, finger pointing); Hands and fingers forming the following: handshake, finger pointing, fingers walking, OK sign, and thumbs up or thumbs down; Handshake (gesture); OK gesture; Thumbs up or thumbs down (gesture)

Attorney of Record

GRANT R. CLAYTON
CLAYTON HOWARTH, P.C.
P.O. BOX 1909
SANDY, UT 84091

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
IC 035. US 100 101 102. G & S: Marketing in the field of cancer treatments containing rivoceranib
IC 042. US 100 101. G & S: Development of therapeutics for the treatment of cancer containing rivoceranib

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:35
U.S. Codes:100,101,102
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
CC0000Color is not claimed as a feature of the mark.

Assignments

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2024-02-14
SOU TEAS EXTENSION RECEIVED2024-02-13
SOU EXTENSION 5 GRANTED2024-02-13
SOU EXTENSION 5 FILED2024-02-13
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2023-08-22
SOU EXTENSION 4 GRANTED2023-08-21
CASE ASSIGNED TO INTENT TO USE PARALEGAL2023-08-21
SOU TEAS EXTENSION RECEIVED2023-08-15
SOU EXTENSION 4 FILED2023-08-15
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2023-02-17
SOU TEAS EXTENSION RECEIVED2023-02-15
SOU EXTENSION 3 GRANTED2023-02-15
SOU EXTENSION 3 FILED2023-02-15
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-08-03
TEAS EXTENSION RECEIVED2022-08-01
SOU TEAS EXTENSION RECEIVED2022-08-01
SOU EXTENSION 2 GRANTED2022-08-01
SOU EXTENSION 2 FILED2022-08-01
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2022-06-08
TEAS CHANGE OF OWNER ADDRESS RECEIVED2022-06-08
TEAS CHANGE OF CORRESPONDENCE RECEIVED2022-06-08
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2022-06-08
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2022-06-08
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-02-19
TEAS EXTENSION RECEIVED2022-02-17
SOU TEAS EXTENSION RECEIVED2022-02-17
SOU EXTENSION 1 GRANTED2022-02-17
SOU EXTENSION 1 FILED2022-02-17
EXTENSION 1 GRANTED2022-02-1798765
EXTENSION 1 FILED2022-02-1798765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2021-08-17
PUBLISHED FOR OPPOSITION2021-06-22
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-06-22
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-06-02
TEAS/EMAIL CORRESPONDENCE ENTERED2021-05-19
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2021-05-19
EXAMINERS AMENDMENT E-MAILED2021-05-19
EXAMINERS AMENDMENT -WRITTEN2021-05-19
EXAMINER'S AMENDMENT ENTERED2021-05-19
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-05-19
APPROVED FOR PUB - PRINCIPAL REGISTER2021-05-19
ASSIGNED TO LIE2021-05-17
TEAS RESPONSE TO OFFICE ACTION RECEIVED2021-02-09
NOTIFICATION OF NON-FINAL ACTION E-MAILED2021-01-08
NON-FINAL ACTION WRITTEN2021-01-08
NON-FINAL ACTION E-MAILED2021-01-08
PREVIOUS ALLOWANCE COUNT WITHDRAWN2021-01-04
WITHDRAWN FROM PUB - OG REVIEW QUERY2020-12-29
APPROVED FOR PUB - PRINCIPAL REGISTER2020-12-15
TEAS/EMAIL CORRESPONDENCE ENTERED2020-12-14
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-12-14
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-12-14
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-06-12
NON-FINAL ACTION WRITTEN2020-06-12
NON-FINAL ACTION E-MAILED2020-06-12
TEAS/EMAIL CORRESPONDENCE ENTERED2020-05-18
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-05-16
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-05-16
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-11-16
NON-FINAL ACTION WRITTEN2019-11-16
NON-FINAL ACTION E-MAILED2019-11-16
ASSIGNED TO EXAMINER2019-11-12
NOTICE OF DESIGN SEARCH CODE E-MAILED2019-09-25
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-09-24
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2019-09-24
NEW APPLICATION ENTERED IN TRAM2019-09-20
NEW APPLICATION ENTERED2019-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed